Sharon O'Kane


Non-Executive Director and Business Advisor

Sharon is a founder and until February 2010 was the Chief Scientific Officer and a Director at Renovo Group plc, which focused on the discovery and development of drugs to reduce scarring. She has a portfolio of non-executive director and business advisory roles, is a member of the MRC/ ABPI Inflammation and Immunology Steering Group, and a judge of the BBSRC Innovator of the Year competition. At Renovo, which floated on the London Stock Exchange in 2006, Sharon was responsible for the R&D capabilities and management of research and development, from early stage discovery through all stages of preclinical development to clinical trials supply. Prior to Renovo, she had a 15-year career based in academia, and has a PhD and BSc (First Class) Honours degree from the University of Ulster. Sharon was awarded a Diploma in Company Direction from the Institute of Directors in 2006


Funding Partners: